# FDA recall D-0630-2021

> **McKesson Corporation dba McKesson Drug Company** · Class III · drug recall initiated 2021-05-26.

## Product

Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141  Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India  NDC 63739-795-10

## Reason for recall

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0630-2021
- **Recalling firm:** McKesson Corporation dba McKesson Drug Company
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-05-26
- **Report date:** 2021-06-16
- **Termination date:** 2022-09-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Memphis, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0630-2021

## Citation

> AI Analytics. FDA recall D-0630-2021. Retrieved 2026-07-09 from https://api.ai-analytics.org/recall/D-0630-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*